RESPECT PFO Clinical Trial

Active, not recruiting

Phase 2 Results N/A

Summary of Purpose

The purpose of this study is to investigate whether percutaneous Patent Foramen Ovale (PFO) closure, using the AMPLATZER PFO Occluder, is superior to current standard of care medical treatment in the prevention of recurrent embolic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 July 2016.

1 Aug 2003 23 Apr 2007 1 Dec 2011 1 Dec 2016 1 Jul 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts